HETEROGENEITY OF INSULIN-LIKE GROWTH FACTOR-I AFFINITY FOR THE INSULIN-LIKE GROWTH FACTOR-II RECEPTOR - COMPARISON OF NATURAL, SYNTHETIC AND RECOMBINANT-DNA DERIVED INSULIN-LIKE GROWTH FACTOR-I

被引：64

作者：

ROSENFELD, RG ^{[1
]}

CONOVER, CA ^{[1
]}

HODGES, D ^{[1
]}

LEE, PDK ^{[1
]}

MISRA, P ^{[1
]}

HINTZ, RL ^{[1
]}

LI, CH ^{[1
]}

机构：

[1] UNIV CALIF SAN FRANCISCO,MOLEC ENDOCRINOL LAB,SAN FRANCISCO,CA 94143

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1987年 / 143卷 / 01期

关键词：

D O I：

10.1016/0006-291X(87)90650-4

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：199 / 205

页数：7

共 50 条

[41] A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor-dependent tumor growth in vivo [J].

Ji, Qun-Sheng ;

Mulvihill, Mark J. ;

Rosenfeld-Franklin, Maryland ;

Cooke, Andrew ;

Feng, Lixin ;

Mak, Gilda ;

O'Connor, Matthew ;

Yao, Yan ;

Pirritt, Caroline ;

Buck, Elizabeth ;

Eyzaguirre, Alexandra ;

Arnold, Lee D. ;

Gibson, Neil W. ;

Pachter, Jonathan A. .

MOLECULAR CANCER THERAPEUTICS, 2007, 6 (08) :2158-2167

[42] Immunohistochemical analysis of insulin-like growth factor I, insulin-like growth factor I receptor and insulin-like growth factor II in endometriotic tissue and endometrium [J].

Chang, SY ;

Ho, YS .

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1997, 76 (02) :112-117

[43] INSULIN-LIKE GROWTH FACTOR-I IS INTERNALIZED AFTER BINDING TO THE TYPE-I INSULIN-LIKE GROWTH-FACTOR RECEPTOR [J].

GEARY, ES ;

ROSENFELD, RG ;

HOFFMAN, AR .

HORMONE AND METABOLIC RESEARCH, 1989, 21 (01) :1-3

[44] Characterization of cementum derived growth factor as an insulin-like growth factor-I like molecule [J].

Ikezawa, K ;

Hart, CE ;

Williams, DC ;

Narayanan, S .

CONNECTIVE TISSUE RESEARCH, 1997, 36 (04) :309-319

[45] INSULIN-LIKE GROWTH FACTOR-I RECEPTOR BETA-SUBUNIT HETEROGENEITY - EVIDENCE FOR HYBRID TETRAMERS COMPOSED OF INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-RECEPTOR HETERODIMERS [J].

MOXHAM, CP ;

DURONIO, V ;

JACOBS, S .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (22) :13238-13244

[46] RECIPROCAL MODULATION OF INSULIN AND INSULIN-LIKE GROWTH FACTOR-I RECEPTOR AFFINITY BY CALCIUM [J].

BAXTER, RC ;

WILLIAMS, PF .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 116 (01) :62-67

[47] CONSTITUTIVE EXPRESSION OF INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH FACTOR-I RECEPTOR ABROGATES ALL REQUIREMENTS FOR EXOGENOUS GROWTH-FACTORS [J].

PIETRZKOWSKI, Z ;

LAMMERS, R ;

CARPENTER, G ;

SODERQUIST, AM ;

LIMARDO, M ;

PHILLIPS, PD ;

ULLRICH, A ;

BASERGA, R .

CELL GROWTH & DIFFERENTIATION, 1992, 3 (04) :199-205

[48] Differential dissociation kinetics explain the binding preference of insulin-like growth factor binding protein-6 for insulin-like growth factor-II over insulin-like growth factor-I [J].

Marinaro, JA ;

Jamieson, GP ;

Hogarth, PM ;

Bach, LA .

FEBS LETTERS, 1999, 450 (03) :240-244

[49] EXPRESSION OF A TYPE-I INSULIN-LIKE GROWTH-FACTOR RECEPTOR WITH LOW AFFINITY FOR INSULIN-LIKE GROWTH FACTOR-II [J].

GERMAINLEE, EL ;

JANICOT, M ;

LAMMERS, R ;

ULLRICH, A ;

CASELLA, SJ .

BIOCHEMICAL JOURNAL, 1992, 281 :413-417

[50] Cyclolignans as inhibitors of the insulin-like growth factor-I receptor [J].

Larsson, Olle ;

Axelson, Magnus .

CANCER RESEARCH, 2007, 67 (06) :2899-2900

← 1 2 3 4 5 →